Metopirone (Metyrapone)

Metyrapone blocks the adrenal enzyme 11β‑hydroxylase, preventing the final step of cortisol synthesis. This leads to lower cortisol levels and a compensatory rise in ACTH, which can be measured for diagnostic purposes or used therapeutically to control hypercortisolism.

The prescribed dose of Metopirone is determined by the treating physician based on the specific indication, patient characteristics, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for metyrapone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Metopirone, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other cortisol synthesis inhibitors such as ketoconazole, metyrapone offers a more selective inhibition of 11β‑hydroxylase and is often preferred for diagnostic testing. Choice of therapy depends on the clinical scenario, side‑effect profile, and physician experience.

Metopirone tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Keep them away from moisture, direct sunlight, and excessive heat to maintain product stability.

Metopirone is taken orally as a tablet. The exact timing and frequency are prescribed by the healthcare provider, often in relation to diagnostic testing protocols or therapeutic regimens for Cushing's syndrome.

The most serious risks include acute adrenal insufficiency, severe hypertension, significant electrolyte disturbances such as hypokalemia, and rare but serious allergic reactions. Patients should be monitored closely for these events.

Metopirone is contraindicated in patients with known hypersensitivity to metyrapone or any excipients in the tablet, and it should be used with caution in individuals with severe hepatic impairment, uncontrolled hypertension, or active infection without medical supervision.